Better understanding of pancreatic diseases, including pancreatic adenocarcinoma (PDAC), is an urgent medical need, with little advances in preoperative differential diagnosis, preventing rational selection of therapeutic strategies.
The clinical management of pancreatic cancer patients would benefit from the identification of variables distinctively associated to the multiplicity of pancreatic disorders. Read more . . .